INDP
Indaptus Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.73
+3.80%Next report
Analyst consensus
- Next report date
- Nov 17, 2026
- EPS estimate
- -$1.46
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.02
- EPS estimate
- -$1.57
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 11
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +61.0%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$1.57 | -$0.02 | Beat 98.73% | — |
| May 15, 2026 | -$1.87 | -$0.23 | Beat 87.70% | — |
| Mar 17, 2026 | -$4.36 | -$3.10 | Beat 28.90% | — |
| Nov 12, 2025 | -$4.17 | -$2.98 | Beat 28.54% | — |
| Aug 13, 2025 | -$9.24 | -$9.09 | Beat 1.62% | — |
| Mar 13, 2025 | -$0.41 | -$0.38 | Beat 7.32% | — |
| Mar 13, 2024 | -$0.54 | -$0.47 | Beat 12.96% | $1.9K |
| Aug 14, 2023 | -$0.58 | -$0.39 | Beat 32.76% | — |
| May 11, 2023 | -$0.59 | -$0.51 | Beat 13.56% | — |
| Mar 17, 2023 | -$0.52 | -$0.44 | Beat 15.38% | — |
| Nov 10, 2022 | -$0.47 | -$0.42 | Beat 10.64% | — |
| May 12, 2022 | -$0.39 | -$0.41 | Miss -5.13% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 17, 2026